Shares of Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 34.58 and traded as high as GBX 40. Cambridge Cognition shares last traded at GBX 37, with a volume of 74,713 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Panmure Gordon reiterated a “buy” rating and issued a GBX 56 target price on shares of Cambridge Cognition in a research report on Monday, January 19th. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of GBX 56.
View Our Latest Stock Report on COG
Cambridge Cognition Trading Down 3.9%
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Recommended Stories
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
